| Mon, Dec 21, 2009 | | • | Idera Pharmaceuticals Announces Positive Interim Data from Phase 1 Clinical Trial of IMO-2125 in Chronic Hepatitis C Patients
Business Wire (Mon, Dec 21)
| | Fri, Dec 18, 2009 | | • | IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Fri, Dec 18)
| | Fri, Dec 4, 2009 | | • | Idera Pharmaceuticals Appoints Rahul Jasuja, Ph.D., Vice President of Corporate Development
Business Wire (Fri, Dec 4)
| | Wed, Nov 25, 2009 | | • | Idera: Novartis deal ends, Merck pact extended
AP (Wed, Nov 25)
| | • | Novartis terminates pact with Idera
at MarketWatch (Wed, Nov 25)
| | • | Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors as Vaccine Adjuvants
Business Wire (Wed, Nov 25)
| | • | IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement
EDGAR Online (Wed, Nov 25)
| | • | Idera Pharmaceuticals Announces Termination of Asthma and Allergy Research Collaboration Agreement
Business Wire (Wed, Nov 25)
| | Wed, Nov 18, 2009 | | • | Biotech Stocks for a Possible Year-End Rally
at Seeking Alpha (Wed, Nov 18)
| | Tue, Nov 10, 2009 | | • | IDERA PHARMACEUTICALS, INC. Financials
EDGAR Online Financials (Tue, Nov 10)
| | Sun, Nov 8, 2009 | | • | New Star Analyst Rankings for Idera Pharmaceuticals, Inc.
StarMine (Sun, Nov 8)
| | Thu, Nov 5, 2009 | | • | IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Thu, Nov 5)
| | • | IDERA PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Nov 5)
| | • | Idera Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides Pipeline Update
Business Wire (Thu, Nov 5)
| | Tue, Nov 3, 2009 | | • | Idera Pharmaceuticals Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic Hepatitis C Virus Infection, at Liver Meeting 2009
Business Wire (Tue, Nov 3)
| | Fri, Oct 30, 2009 | | • | A.H. Belo, Idera Pharmaceuticals: Biggest Price Gainers (AHC, IDRA)
at The Wall Street Journal Online (Fri, Oct 30)
| | Mon, Oct 26, 2009 | | • | Idera Pharmaceuticals Announces Issuance of Patents Covering its Novel Toll-like Receptor-Targeted Compounds and Their Use
Business Wire (Mon, Oct 26)
| | Mon, Oct 19, 2009 | | • | Idera Pharmaceuticals Presents Preclinical Data at ACR/ARHP 2009 Annual Meeting on IMO-3100, a Toll-Like Receptor Antagonist, in Combination with Enbrel® in Arthritis Model
Business Wire (Mon, Oct 19)
| | Fri, Oct 16, 2009 | | • | Idera Pharmaceuticals to Present at 8th Annual BIO Investor Forum
Business Wire (Fri, Oct 16)
| | Wed, Oct 7, 2009 | | • | Idera launches Phase 1 Hepatitis C trial
at bizjournals.com (Wed, Oct 7)
|
Add IDRA News to My Yahoo!:
 
| |
|
0.49% Nasdaq 0.00%
Headlines
